Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

10.1182/blood-2012-03-415307

Saved in:
Bibliographic Details
Main Authors: Cortes, J., Lipton, J.H., Rea, D., Digumarti, R., Chuah, C., Nanda, N., Benichou, A.-C., Craig, A.R., Michallet, M., Nicolini, F.E., Kantarjian, H.
Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format: Article
Published: 2016
Online Access:http://scholarbank.nus.edu.sg/handle/10635/128647
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1182/blood-2012-03-415307

Similar Items